Literature DB >> 29627896

Clinical connection between rheumatoid arthritis and liver damage.

Biljana Radovanović-Dinić1,2, Snežana Tešić-Rajković3, Valentina Zivkovic4,5, Saša Grgov6.   

Abstract

When liver damage is present in rheumatoid arthritis (RA) patients, it is sometimes difficult to determine whether it is a hepatic manifestation of RA, associated primary liver disease or hepatotoxic liver disease which developed during the treatment of RA. Liver damage during RA is most common in the form of asymptomatic abnormal liver tests. Occasionally, liver damage may progress to cirrhosis. Patients with RA are more susceptible to an associated autoimmune liver disease. Medications used in rheumatology are often hepatotoxic and it is difficult to differentiate between hepatic manifestations of the primary disease and potential hepatotoxicity of the administered medications. The significance of the paper is in the fact that it includes the most relevant and the latest information on this commonly present problem in clinical practice. The aim of the author is to provide comprehensive but at the same time concise data which will be useful to the doctors who come into contact with RA patients with symptomatic or asymptomatic liver disease. Timely diagnosis and treatment of liver disease in RA patients can significantly influence the course and outcome of rheumatoid arthritis.

Entities:  

Keywords:  Arthritis; Biological therapy; Hepatitis; Liver; Rheumatoid

Mesh:

Substances:

Year:  2018        PMID: 29627896     DOI: 10.1007/s00296-018-4021-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  92 in total

Review 1.  Disease-specific autoantibodies in primary biliary cirrhosis.

Authors:  Dimitrios P Bogdanos; Lars Komorowski
Journal:  Clin Chim Acta       Date:  2010-12-23       Impact factor: 3.786

Review 2.  Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors.

Authors:  Armen Yuri Gasparyan; Lilit Ayvazyan; Heather Blackmore; George D Kitas
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

Review 3.  The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.

Authors:  Jung Sub Lim; Michele Mietus-Snyder; Annie Valente; Jean-Marc Schwarz; Robert H Lustig
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

4.  Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis.

Authors:  H Tiwana; C Wilson; R S Walmsley; A J Wakefield; M S Smith; N L Cox; M J Hudson; A Ebringer
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

5.  Hepatic hemorrhage in malignant rheumatoid arthritis.

Authors:  K Mizuno; K Ikeda; Y Saida; R Takenaka; M Shibata; T Takeuchi
Journal:  Am J Gastroenterol       Date:  1996-12       Impact factor: 10.864

6.  Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.

Authors:  J R Curtis; T Beukelman; A Onofrei; S Cassell; J D Greenberg; A Kavanaugh; G Reed; V Strand; J M Kremer
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

7.  Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance.

Authors:  Hideyuki Kojima; Masahito Uemura; Shinya Sakurai; Tatsuichi Ann; Yoshinobu Ishii; Hiroo Imazu; Masahide Yoshikawa; Kunio Ichijima; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

8.  Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?

Authors:  G P Aithal; B Haugk; S Das; T Card; A D Burt; C O Record
Journal:  Aliment Pharmacol Ther       Date:  2004-02-15       Impact factor: 8.171

Review 9.  Liver in systemic disease.

Authors:  Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

Review 10.  Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  T H Karlsen; M Vesterhus; K M Boberg
Journal:  Aliment Pharmacol Ther       Date:  2013-12-29       Impact factor: 8.171

View more
  12 in total

1.  Novel acetamide derivatives of 2-aminobenzimidazole prevent inflammatory arthritis in rats via suppression of pro-inflammatory mediators.

Authors:  Aymun Madni Zubair; Muhammad Nasir Hayat Malik; Waqas Younis; Muhammad Atif Hayat Malik; Shah Jahan; Ishtiaq Ahmed; Alamgeer Yuchi; Muhammad Naveed Mushtaq; Romeeza Tahir; Muhammad Bilal Sarwar; Muhammad Roman; Ayaz Ali Khan; Muhammad Nouman Tahir; Muhammad Tariq Khan; Hafiz Amir Ali Kharl; Gagun Kamran; Abdullah Abdo Albegali; Ali Imran
Journal:  Inflammopharmacology       Date:  2022-04-16       Impact factor: 4.473

Review 2.  Mechanistic and therapeutic links between rheumatoid arthritis and diabetes mellitus.

Authors:  Jing Li; Yazhuo Chen; Qingyun Liu; Zhufang Tian; Yan Zhang
Journal:  Clin Exp Med       Date:  2022-03-20       Impact factor: 3.984

3.  Xanthorrhizol Ameliorates Oxidative Stress and Inflammation in Freund's Complete Adjuvant-Induced Rheumatoid Arthritis in Rats.

Authors:  Ming Zhou; Yaya Li; Huiming Hou; Wen Zou; Liangshen Hu; Li Gong; Wei Fan; Rongqing Wang; Ibrahim Abdel Aziz Ibrahim; Shaoyong Fan
Journal:  Appl Biochem Biotechnol       Date:  2022-08-06       Impact factor: 3.094

Review 4.  Hepatitis E Virus and rheumatic diseases: what do rheumatologists need to know?

Authors:  Salvatore Di Bartolomeo; Francesco Carubbi; Paola Cipriani
Journal:  BMC Rheumatol       Date:  2020-09-21

5.  Anti-inflammatory and Hepatoprotective Effects of Quercetin in an Experimental Model of Rheumatoid Arthritis.

Authors:  Ana Carolina de Figueiredo Costa; Luane Macedo de Sousa; Joana Maria Dos Santos Alves; Paula Goes; Karuza Maria Alves Pereira; Ana Paula Negreiros Nunes Alves; Mariana Lima Vale; Delane Viana Gondim
Journal:  Inflammation       Date:  2021-06-02       Impact factor: 4.092

6.  Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide: A case report with emphasis on geoepidemiology.

Authors:  Francesco Carubbi; Giovanna Picchi; Salvatore Di Bartolomeo; Alessandra Ricciardi; Paola Cipriani; Laura Marola; Alessandro Grimaldi; Roberto Giacomelli
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 7.  Endothelial Dysfunction and Extra-Articular Neurological Manifestations in Rheumatoid Arthritis.

Authors:  Jessica Maiuolo; Carolina Muscoli; Micaela Gliozzi; Vincenzo Musolino; Cristina Carresi; Sara Paone; Sara Ilari; Rocco Mollace; Ernesto Palma; Vincenzo Mollace
Journal:  Biomolecules       Date:  2021-01-10

8.  2-Deoxy-D-glucose Alleviates Collagen-Induced Arthritis of Rats and Is Accompanied by Metabolic Regulation of the Spleen and Liver.

Authors:  Hongxing Wang; Nanyang Zhang; Kehua Fang; Xiaotian Chang
Journal:  Front Immunol       Date:  2021-09-01       Impact factor: 7.561

9.  Dkk1 inhibits malignant transformation induced by Bmi1 via the β-catenin signaling axis in WB-F344 oval cells.

Authors:  Jinjun Ye; Le Xin; Jidong Liu; Tao Tang; Xing Bao; Yukuang Yan
Journal:  FEBS Open Bio       Date:  2021-06-09       Impact factor: 2.693

10.  [Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib].

Authors:  Larissa Valor-Méndez; Bernhard Manger; Georg Schett; Arnd Kleyer
Journal:  Z Rheumatol       Date:  2021-06-07       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.